According to a recent LinkedIn post from Resilience Care, the company is present at the Société Française d’Hématologie congress in Paris from March 25 to 27. The post highlights that its team is available at stand 15 to discuss telemonitoring and new approaches to follow-up for hematology patients.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests that Resilience Care is actively engaging with hematology specialists, which may support adoption of its digital or remote-monitoring solutions in this therapeutic area. For investors, this type of presence at a major medical congress can be seen as business development activity that could enhance clinical visibility, strengthen partnerships with healthcare professionals, and potentially expand the company’s addressable market in hematology over time.